Loganic acid protects against ulcerative colitis by inhibiting TLR4/NF-κB mediated inflammation and activating the SIRT1/Nrf2 anti-oxidant responses in-vitro and in-vivo

Autor: Prakash, Arun N., Prasad, Neethu, Puppala, Eswara Rao, Panda, Samir Ranjan, Jain, Siddhi, Ravichandiran, V., Singh, Meenakshi, Naidu, V.G.M.
Zdroj: In International Immunopharmacology September 2023 122
Databáze: ScienceDirect